fluorodopa f 18 has been researched along with Multiple Endocrine Neoplasia Type 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Barlier, A; Brue, T; Castinetti, F; Cuny, T; D'Anella, P; Jullien, M; Reichert, T; Taieb, D | 1 |
1 other study(ies) available for fluorodopa f 18 and Multiple Endocrine Neoplasia Type 1
Article | Year |
---|---|
Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
Topics: Dihydroxyphenylalanine; Female; Humans; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |